| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Allogeneic Hematopoietic Cell Transplantation for Leukemic Transformation Preceded by Philadelphia Chromosome–Negative Myeloproliferative Neoplasms: A Nationwide Survey by the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation
|
Takagi, Shinsuke
|
|
2016
|
22 |
12 |
p. 2208-2213
|
artikel
|
| 2 |
A Phase I/II Study of Escalating Doses of Bortezomib in Conjunction with High-Dose Melphalan as a Conditioning Regimen for Salvage Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma
|
Biran, Noa
|
|
2016
|
22 |
12 |
p. 2165-2171
|
artikel
|
| 3 |
A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation
|
Khandelwal, Pooja
|
|
2016
|
22 |
12 |
p. 2220-2225
|
artikel
|
| 4 |
Azithromycin for the Treatment of Obliterative Bronchiolitis after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
|
Yadav, Hemang
|
|
2016
|
22 |
12 |
p. 2264-2269
|
artikel
|
| 5 |
Bone Marrow and Peripheral Blood: Which Is Safe?
|
Imataki, Osamu
|
|
2016
|
22 |
12 |
p. 2283-2284
|
artikel
|
| 6 |
Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation
|
Kharfan-Dabaja, Mohamed A.
|
|
2016
|
22 |
12 |
p. 2117-2125
|
artikel
|
| 7 |
Comparison of Cyclophosphamide Combined with Total Body Irradiation, Oral Busulfan, or Intravenous Busulfan for Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Lymphoblastic Leukemia
|
Mitsuhashi, Kenjiro
|
|
2016
|
22 |
12 |
p. 2194-2200
|
artikel
|
| 8 |
Comparison of Donor Sources in Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Nationwide Retrospective Study
|
Sakaguchi, Hirotoshi
|
|
2016
|
22 |
12 |
p. 2226-2234
|
artikel
|
| 9 |
Decline in the Use of Surgical Biopsy for Diagnosis of Pulmonary Disease in Hematopoietic Cell Transplantation Recipients in an Era of Improved Diagnostics and Empirical Therapy
|
Cheng, Guang-Shing
|
|
2016
|
22 |
12 |
p. 2243-2249
|
artikel
|
| 10 |
Early Natural Killer Cell Reconstitution Predicts Overall Survival in T Cell–Replete Allogeneic Hematopoietic Stem Cell Transplantation
|
Minculescu, Lia
|
|
2016
|
22 |
12 |
p. 2187-2193
|
artikel
|
| 11 |
Editorial Board
|
|
|
2016
|
22 |
12 |
p. A6
|
artikel
|
| 12 |
Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia
|
Gadalla, Shahinaz M.
|
|
2016
|
22 |
12 |
p. 2276-2282
|
artikel
|
| 13 |
Effects of Donor Vitamin A Deficiency and Pharmacologic Modulation of Donor T Cell Retinoic Acid Pathway on the Severity of Experimental Graft-versus-Host Disease
|
Dodge, Joseph
|
|
2016
|
22 |
12 |
p. 2141-2148
|
artikel
|
| 14 |
Erratum to “Increased Type 1 Immune Response in the Bone Marrow Immune Microenvironment of Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation” [Biol Blood Marrow Transplant 2016;22:1376-1382]
|
Wang, Yu-Tong
|
|
2016
|
22 |
12 |
p. 2285
|
artikel
|
| 15 |
Erratum to: “Metabolic Syndrome after Hematopoietic Cell Transplantation: At the Intersection of Treatment Toxicity and Immune Dysfunction” [Biol Blood Marrow Transplant 2016;22:1159-1166]
|
Turcotte, Lucie M.
|
|
2016
|
22 |
12 |
p. 2286
|
artikel
|
| 16 |
For Whom the Bell Tolls: Programmed Death 1 as a Marker of Post-Transplantation Mortality
|
Robinson, Tara M.
|
|
2016
|
22 |
12 |
p. 2115-2116
|
artikel
|
| 17 |
Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome
|
Greco, Raffaella
|
|
2016
|
22 |
12 |
p. 2250-2255
|
artikel
|
| 18 |
Induction of Immune Response after Allogeneic Wilms' Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation Relapse
|
Shah, Nirali N.
|
|
2016
|
22 |
12 |
p. 2149-2154
|
artikel
|
| 19 |
Long-Lasting Protective Effect of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell Transplantation
|
Busca, Alessandro
|
|
2016
|
22 |
12 |
p. 2214-2219
|
artikel
|
| 20 |
Masthead (Purpose and Scope)
|
|
|
2016
|
22 |
12 |
p. A4
|
artikel
|
| 21 |
Myeloablative versus Reduced-Intensity Conditioning in Patients with Myeloid Malignancies: A Propensity Score-Matched Analysis
|
Sibai, Hassan
|
|
2016
|
22 |
12 |
p. 2270-2275
|
artikel
|
| 22 |
Nonfluorodeoxyglucose-Avid Persistent Splenomegaly at Time of Transplantation Delays Neutrophil and Platelets Engraftment without Affecting Survival in Patients with Lymphomas Undergoing Allogeneic Hematopoietic Cell Transplantation
|
Khimani, Farhad
|
|
2016
|
22 |
12 |
p. 2201-2207
|
artikel
|
| 23 |
Officers and Directors of ASBMT
|
|
|
2016
|
22 |
12 |
p. A8
|
artikel
|
| 24 |
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Chronic and Advanced Phase Myelofibrosis
|
Keyzner, Alla
|
|
2016
|
22 |
12 |
p. 2180-2186
|
artikel
|
| 25 |
Outcome of Patients with Multiple Myeloma and CKS1B Gene Amplification after Autologous Hematopoietic Stem Cell Transplantation
|
Bock, Fabian
|
|
2016
|
22 |
12 |
p. 2159-2164
|
artikel
|
| 26 |
Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial
|
Knight, Jennifer M.
|
|
2016
|
22 |
12 |
p. 2256-2263
|
artikel
|
| 27 |
Phase II Study of Propylene Glycol–Free Melphalan Combined with Carmustine, Etoposide, and Cytarabine for Myeloablative Conditioning in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
|
Cashen, Amanda F.
|
|
2016
|
22 |
12 |
p. 2155-2158
|
artikel
|
| 28 |
Programmed Death 1 Expression on CD4+ T Cells Predicts Mortality after Allogeneic Stem Cell Transplantation
|
Schade, Henning
|
|
2016
|
22 |
12 |
p. 2172-2179
|
artikel
|
| 29 |
Refining the Role of Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia as Novel Therapies Emerge
|
El Fakih, Riad
|
|
2016
|
22 |
12 |
p. 2126-2133
|
artikel
|
| 30 |
Strategies and Challenges for Pharmacological Maintenance Therapies after Allogeneic Hematopoietic Cell Transplantation
|
DeFilipp, Zachariah
|
|
2016
|
22 |
12 |
p. 2134-2140
|
artikel
|
| 31 |
Table of Contents
|
|
|
2016
|
22 |
12 |
p. A9-A16
|
artikel
|
| 32 |
Timing Is Everything: Combining Post-Transplantation Adoptive Cell Therapy and Tumor Vaccines
|
Perales, Miguel-Angel
|
|
2016
|
22 |
12 |
p. 2113-2114
|
artikel
|
| 33 |
Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation in First Complete Remission Can Abrogate the Poor Outcomes of Children with Acute Myeloid Leukemia Resistant to the First Course of Induction Chemotherapy
|
Mo, Xiao-Dong
|
|
2016
|
22 |
12 |
p. 2235-2242
|
artikel
|
Tijdschrift beschrijving